A tumor PD-L1-NLRP3 inflammasome signaling axis drives adaptive resistance to anti-PD-1 immunotherapyBalamayooran Theivanthiran,Kathy Evans,Nicholas DeVito,Michael Plebanek,Michael Sturdivant,Alisha Holtzhausen,Luke Wachsmuth,April Salama,Yubin Kang,David Hsu,Justin Balko,Douglas Johnson,Mark Starr,Andrew Nixon,Brent HanksJOURNAL FOR IMMUNOTHERAPY OF CANCER（2019）引用 0|浏览32暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
